InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
KDL | The End? | 26/07/18 | 3 | 2.3K | |||
|
|||||||
KDL | ASIC 15-258MR Editor's note 6: | 27/07/17 | 13 | 7.2K | |||
|
|||||||
KDL | Ann: Suspension from Official Quotation | 21/03/17 | 1 | 995 | |||
|
|||||||
KDL | Ann: Removal from Official List | 21/03/17 | 0 | 392 | |||
|
|||||||
KDL | Ann: Change in substantial holding | 15/03/17 | 0 | 399 | |||
|
|||||||
KDL | Ann: Timing of Delisting From Official List of the ASX | 02/03/17 | 3 | 2.0K | |||
|
|||||||
KDL | Ann: Appendix 3B | 22/02/17 | 0 | 286 | |||
|
|||||||
KDL | Ann: Change in substantial holding | 22/02/17 | 0 | 291 | |||
|
See All Discussions